The Effect of Single-Dose Antenatal Dexamethasone in Reducing Respiratory Complications in Late Preterm

Article Sidebar

Fulltext
Published: Apr 1, 2020
DOI: https://doi.org/10.14456/tjog.2020.14
Keywords:
late preterm respiratory complications corticosteroids dexamethasone

Main Article Content

Adisak Waiketkarn
Department of Obstetrics and Gynecology, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand
Charintip Somprasit
Department of Obstetrics and Gynecology, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand
Chamnan Tanprasertkul
Department of Obstetrics and Gynecology, Faculty of Medicine, Thammasat University, Pathum Thani, Thailand

Abstract

Objective: To determine the effect of a single dose of dexamethasone in reducing respiratory complications in late preterm newborns.


Materials and Methods: This was a prospective cohort study. Pregnant women who were at risk of preterm births at 340/7-36 6/7weeks of gestation were prospectively observed. The first group was given single dose of antenatal dexamethasone, while the second group received only the standard treatment without dexamethasone as the control group. The main outcomes are rate of respiratory complications in newborns.


Results: A total of 205 pregnant women who were enrolled with complete data for analysis. Sixty-eight and 137 were in the single dose and control groups, respectively. The rates of respiratory complications in all gestational ages between the two groups were not significantly different (22.1% and 32.8%, respectively: p=0.11). Multivariate logistic regression model was utilized to adjust confounders for independent factors of respiratory complications in late preterm newborns. A single dose of dexamethasone and gestational age at 360/7-6/7weeks became significant factors in order to decrease respiratory complication rate and received an adjusted odd ratio (aOR) of 0.45 and 0.29 at p=0.03 and p=0.001, respectively.


Conclusion: Administration of a single dose of dexamethasone is a factor in reducing rate of respiratory complications in late preterm newborns without any seriously adverse effects.

Article Details

How to Cite
(1)
Waiketkarn, A.; Somprasit, C.; Tanprasertkul, C. The Effect of Single-Dose Antenatal Dexamethasone in Reducing Respiratory Complications in Late Preterm. Thai J Obstet Gynaecol 2020, 28, 103-111.
Issue
VOL. 28, NO. 2: (April - June 2020)
Section
Original Article

References

1. Committee on Obstetric Practice. Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation. Obstet Gynecol 2017;130: e102-9.
2. Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2017; 3: CD004454.
3. Cunningham FG, Lenovo JK, Bloom SL, Dashe JS, Hoffman BL, Casey BM, et al. Willliams Obstetrics. 25th ed. New York: McGraw-Hill, 2018: 803-34.
4.Society for Maternal-Fetal Medicine (SMFM) Publications Committee. Implementation of the use of antenatal corticosteroids in the late preterm birth period in women at risk for preterm delivery. Am J Obstet Gynecol 2016; 215: B13-5.
5. Brownfoot FC, Gagliardi DI, Bain E, Middleton P, Crowther CA. Different corticosteroids and regimens for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2013;8:CD006764.
6. Cunningham FG, Lenovo JK, Bloom SL, Dashe JS, Hoffman BL, Casey BM, et al. Willliams Obstetrics. 25th ed. New York: McGraw-Hill, 2018: 619-35.
7. Cunningham FG, Lenovo JK, Bloom SL, Dashe JS, Hoffman BL, Casey BM, et al. 8. Willliams Obstetrics. 25th ed. New York: McGraw-Hill, 2018: 606-18.
8. Balci O, Ozdemir S, Mahmoud AS, Acar A, Colakoglu MC. The effect of antenatal steroids on fetal lung maturation between the 34th and 36th week of pregnancy. Gynecol Obstet Invest 2010;70: 95-9.
9. Consortium on Safe Labor, Hibbard JU, Wilkins I, Sun L, Gregory K, Haberman S, et al. Respiratory morbidity in late preterm births. JAMA 2010; 304: 419-25.
10. Porto AM, Coutinho IC, Correia JB, Amorim MM. Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial. BMJ 2011; 342: d1696.
11. Bastek JA, Sammel MD, Paré E, Srinivas SK, Posencheg MA, Elovitz MA. Adverse
neonatal outcomes: examining the risks between preterm, late preterm, and term
infants. Am J Obstet Gynecol 2008;199: 367.e1-8.
12. Saccone G, Berghella V. Antenatal corticosteroids for maturity of term or near term fetuses: systematic review and meta-analysis of randomized controlled trials. BMJ 2016; 355: i5044.
13. ACOG Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin no. 171: Management of preterm labor. Obstet Gynecol 2016; 128: 931-3.
14. Attawattanakul N, Tansupawatdikul P. Effects of antenatal dexamethasone on respiratory distress in late preterm infant. Thai J Obstet Gynaecol 2015; 23: 25-33
15. Jain L, Eaton DC. Physiology of fetal lung fluid clearance and the effect of labor. Semin Perinatol 2006; 30: 34-43.
16. Gyamfi-Bannerman C, Thom EA, Blackwell SC, Tita AT, Reddy UM, Saade GR, et al. NICHD Maternal–Fetal Medicine Units Network. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. N Engl J Med 2016; 374:1311-20.